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Abstract There is an increasing interest in screening
methods for quick and sensitive analysis of various classes
of veterinary drugs with limited sample pre-treatment.
Turbulent flow chromatography in combination with
tandem mass spectrometry has been applied for the first
time as an efficient screening method in routine analysis of
milk samples. Eight veterinary drugs, belonging to seven
different classes were selected for this study. After
developing and optimising the method, parameters such as
linearity, repeatability, matrix effects and carry-over were
studied. The screening method was then tested in the
routine analysis of 12 raw milk samples. Even without
internal standards, the linearity of the method was found to
be good in the concentration range of 50 to 500 µg/L.
Regarding repeatability, RSDs below 12% were obtained
for all analytes, with only a few exceptions. The limits of
detection were between 0.1 and 5.2 µg/L, far below the
maximum residue levels for milk set by the EU regulations.
While matrix effects—ion suppression or enhancement—
are obtained for all the analytes the method has proved to
be useful for screening purposes because of its sensitivity,
linearity and repeatability. Furthermore, when performing
the routine analysis of the raw milk samples, no false
positive or negative results were obtained.
Keywords Veterinary drugs .Milk . Turbulent flow .
Screening . Tandem mass spectrometry
Introduction
Incorrect use of drugs in veterinary practice may leave
residues in edible tissues that can have direct toxic-effects
on consumers. The EU has set maximum residue limits
(MRLs) for a variety of veterinary drugs in tissues, milk
and eggs [1, 2]. In order to detect such residues in food and
tissues, microbiological or bioassay techniques are widely
used as screening methods. These methods generally do not
distinguish between members of a class of antibiotics, but
provide a semi-quantitative estimate of ‘total’ residues
detected. Nevertheless, they continue to be used because
of their simplicity and low cost.
The cost-effectiveness of analytical procedures is be-
coming an important issue for all laboratories involved in
residue analysis. A way to improve cost-effectiveness is to
maximise the number of analytes that may be determined
by a single procedure or from a single portion of test
material, and/or to limit the sample pre-treatment steps.
Many analytical methods for the determination of residues
of veterinary drugs using different extraction procedures,
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clean-up conditions and detection principles are available.
In general, a liquid–liquid extraction (LLE) is performed
followed by an extract clean-up and concentration step
using solid-phase extraction (SPE), separation and detection
by liquid chromatography tandem mass spectrometry
(LC-MS/MS) [3]. Furthermore, most of the procedures
described are dealing with one group of analytes or one
class of veterinary drugs.
Recently, some multi-residue methods for the analysis of
drugs in milk have been published. Turnipseed et al. [4]
described a method for the analysis of different classes of
veterinary drugs in milk using LLE followed by SPE and
LC-MS/MS. Gaugain-Juhel et al [5] monitored 58 analytes
in milk using a simple LLE followed by LC-MS/MS.
However, not all classes of veterinary drugs were tested on
the described studies. Instead, only antibiotic compounds
have been used. Aguilera-Luiz et al. [6] reported an
interesting approach using the so called QuEChERS (quick,
easy, cheap, effective, rugged and safe) extraction tech-
nique. This extraction although relatively quick still
included several sample handling steps like LLE, centrifu-
gation, addition of an adsorbent, centrifugation, dilution
and others.
Recently, Kinsella et al. presented a comprehensive
review on the current trends in sample preparation for the
isolation of veterinary drugs and growth promoters from
foods. Turbulent flow chromatography coupled with tan-
dem mass spectrometry (TFC-LC-MS/MS) was described
as a technique that eliminates time-consuming sample
clean-up, increases productivity and reduces solvent con-
sumption without sacrificing sensitivity or productivity [7].
TFC was introduced in the late 1990s as a technique for
the direct injection of biological fluids onto a column
packed with 50 µm spherical porous particles [8, 9].
Nowadays, TFC can be used as a high-throughput sample
preparation technique that makes use of high flow rates in
0.5 or 1.0 mm internal diameter columns packed with
particles in the size range of 30–60 µm. Due to these large
particle sizes, there is only moderate back-pressure on the
column. Samples are applied to the column using an
aqueous mobile phase as illustrated in Fig. 1 [10]. Small
molecules diffuse more extensively than macromolecules
(e.g., proteins, lipids, sugars) and are driven into the pores
of the sorbent. Due to the high flow rate, the larger
molecules and matrix constituents are flushed to waste and
do not have an opportunity to diffuse into the particle pores.
The trapped analytes are desorbed from the TFC column by
back-flushing it with an organic solvent and the eluate can
be transferred with a switching valve onto the analytical
LC-MS/MS system for further separation and detection.
Although TFC is a promising technique for rapid sample
preparation, very few uses in residue analysis have been
reported in the literature. Mottier et al. carried out
quantitative analysis of 16 quinolones in honey using
TFC coupled on-line to LC-MS/MS [11]. Sample prepara-
tion involved simple dilution with water followed by
filtration and transfer of an aliquot into a vial. Sample
extraction time was 4.5 min, while the overall analysis took
18.5 min. Recovery of the method ranged from 85% to
127%, while the LOD of the method was 5 µg/kg. Krebber
et al. used TFC-LC-MS/MS for the rapid determination of
enrofloxacin and ciprofloxacin in edible tissues [12]. Tissue
samples (bovine, porcine, turkey, rabbit) were extracted
with acetonitrile:water:formic acid, filtered and an aliquot
injected onto the TFC-LC-MS/MS system. The run time for
the analysis was 4 min. The LOQ of the method was
25 µg/kg in all matrices. The recovery of the method
ranged from 72% to 105%. So far, TFC is only used for the
analysis of compound of one specific class of veterinary
drugs. In this study TFC-LC-MS/MS is applied to the
analysis of residues of multi-class antibiotics in milk.
The selected veterinary drugs were the benzimidazole:
albendazole, the sulphonamide: sulphamethazine, the non-
steroidal anti-inflammatory agent (NSAID): phenylbuta-
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Fig. 1 Schematic representation
of the loading step in an Aria
TLX-2 system. The sample is
introduced into the system by an
autosampler and a loading
pump. The system also involves
a solvent holding loop
connected to valve A. This loop
contains a solvent mixture
strong enough to elute the
analytes from the TurboFlow
column (TFC) into the analytical
column (transfer step). An
eluting pump delivers a mixture
of solvents and enables a normal
chromatographic separation
and detection
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zone, the quinolone: difloxacin, the macrolide: spiramycin,
the tetracyclines: tetracycline and oxytetracycline and the
ionofore: salinomycin-Na. Milk was selected as the test
matrix because it is an important matrix for residue control
which can contain residues from different classes of
veterinary drugs. Different milk samples, containing differ-
ent fat percentages were studied. Finally, the method has
been tested in a routine environment, where 12 raw milk
samples were analysed and compared with the data
obtained when analysing the same batch of samples by a
different method. The results of method development and
application will be described and discussed.
Materials
Chemicals, reagents and solutions
Methanol, acetonitrile, ammonium acetate, sodium EDTA,
formic acid, trifluoroacetic acid, propanol and acetone were
obtained from Biosolve (Valkenswaard, the Netherlands).
The analytical standards albendazole, pheylbutazone,
spiramycin, tetracycline, oxytetracycline and salinomycin-
Na were purchased from Sigma-Aldrich Chemie b.v
(Zwijndrecht, the Netherlands). The analytical standards
of sulphamethazine (sulphadimidine) and difloxacin were
purchased from Riedel de Haen (Seelze, Germany).
A diluent consisting of: 50 mM ammonium acetate +
7.5 mM sodium EDTA in water/acetonitrile (1/1; v/v) was
prepared to induce protein precipitation.
Individual veterinary drug stock solutions (0.1, 1 or 2 mg/ml)
were prepared in puremethanol and stored at −18°C. Themixed
standard solution containing all eight veterinary drugs was
prepared in diluent, stored at −18°C and used for 1 week.
Samples
Whole (fat content approximately 3%), skimmed (fat content
<0.5%) and semi-skimmed (fat content 1.5–2%) milk samples
were used for method development. These test samples were
obtained from a local supermarket in Pennsylvania, USA.
All milk samples used for the application test were raw (not
pasteurised) milk samples. The samples were collected by the
Dutch Food and Consumer Product Safety Authority, Labora-
tory Region East (Wageningen, The Netherlands) at farm-
houses during the spring of 2009. The samples were received in
frozen conditions and were kept frozen (−18°C) until analysis.
Equipment
A turbulent flow chromatograph Aria TLX-2 system (Thermo
Fisher Scientific, Franklin, MA) was used for these experi-
ments and was comprised of a PAL autosampler (CTC
Analytics, Zwingen, Switzerland), a low-pressure mixing
quaternary pump (loading pump), a high-pressure mixing
binary pump (eluting pump) and a three-valve switching device
unit with six-port valve. The entire system was controlled via
Aria software, version 1.6. The TurboFlow TFC columns used
were connected in tandem: Cyclone, 50×0.5 mm, 60 μm
particle size, 60Å pore size and Cyclone P 50×0.5 mm, 60 μm
particle size, 60Å pore size (Thermo Fisher Scientific,
Franklin, MA); whereas the analytical HPLC column was a
Betasil Phenyl Hexyl column 3.0×50, 3 µm; Thermo Fisher
Scientific, Runcorn, UK. The temperature of the analytical
column was maintained at 50°C using a column heater.
The triple quadrupole mass spectrometer was a TSQ
Quantum Ultra (Thermo Fisher Scientific, San Jose, CA)
equipped with a heated electrospray ionisation probe that was
kept at 475°C. All analyses were performed in the positive
ionisation mode with a spray voltage set at 3,500 V. The
sheath, auxiliary and ion sweep gas used was nitrogen at 50,
25 and 2 arbitrary units, respectively. The system was
operated in the selected reaction monitoring (SRM) mode
with argon as the collision gas at a pressure of 1.5 mTorr. The
ion transfer tube was kept at 250°C while the scan time and
width were 0.10 s and 0.02m/z, respectively. Data were
processed using LCQuan software version 2.6.
Methods
Sample preparation
Protein precipitation was induced by mixing 100 µL of
milk sample with 900 µL of diluent. After centrifugation of
the mixture at 10,000 rpm for 10 min, the supernatant was
collected and 50 µL analysed by TFC-LC-MS/MS.
Chromatographic conditions
The gradient used is illustrated in Table 1. The solvent
system used was as follows:
Loading pump A: 0.1% formic acid and 0.05% trifluoro-
acetic acid in water; B: methanol; C: isopropanol: acetone
(1/1, v/v); D: 2% acetonitrile and 0.1% ammonium
hydroxide in water.
Eluting pump A: 0.1% formic acid and 0.01% trifluoro-
acetic acid in water; B: methanol.
Detection
The TFC-LC-MS/MS analysis was carried out using the
conditions stated in the “Equipment” section. The optimi-
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zation of the SRM parameters was performed by direct
infusion of the standards using positive electrospray
ionisation. Collision-induced dissociation (CID) mass spec-
tra were recorded for each analyte and the optimum
collision energies determined for the selected ion transi-
tions. Two transitions were monitored for each analyte as
represented in Table 2.
Method validation
The method was validated based on the criteria for
screening methods as described by the EU (Commission
Decision 2002/657/EC [13]). For screening methods it is
necessary to determine the beta-error of the screening
method. In this study, the standard mixture of veterinary
drugs was added to three different milk samples at four
concentration levels viz. 50-100-250-500 µg/L. All analysis
were performed in triplicate. In this way a total number of
4×3×3 samples are analysed per analyte. Samples were
analysed together with a calibration curve of neat standard
solutions in the concentration range of 5–500 µg/L. When
all the fortified samples are screening ‘positive’, the method
will be accepted. From this experiment, the linearity,
repeatability, limit of detection, carry-over and matrix effect
were also determined. Furthermore, the robustness of the
method was tested by the analysis of samples with different
fat content.
The linearity of the analytical method was studied by
preparing calibration curves at different concentration
levels. The calibration curves were constructed by means
of plotting the detection response of the matrix matched
standard solutions (spiked samples) versus the concentra-
tions by means of regression analysis. From these data, the
regression coefficients (r2) of the calibration curves were
calculated. Criterion for good linearity: r2>0.99.
The repeatability was determined by the analysis of three
replicates of each test sample. The repeatability—expressed
as RSD (%)—was automatically calculated using the
quantification software. Criterion for good repeatability
was set at RSD<15%.
Limits of detection (LODs) were set at those concentra-
tion levels in matrix showing S/N of 6.
For automatic sample pre-treatment, it is important to
know if there is carry-over of the analyte from one injection
to the next. By analysing spiked samples, it was possible to
test the carry-over. First, the spike sample was injected and
directly after that blank from the results the carry-over
percentages were determined.
Loading pump Eluting pump
Step Time (s) Flow (ml/min) A B C D Flow (ml/min) A B
1 30 1.5 100 0.5 100 –
2 90 0.1 100 0.4 100 –
3 15 2.0 100 0.5 75 25
4 15 2.0 100 0.5 50 50
5 15 2.0 100 0.5 40 60
6 15 2.0 100 0.5 30 70
7 15 2.0 100 0.5 20 80
8 15 2.0 100 0.5 – 100
9 60 2.0 100 0.5 – 100
10 30 2.0 100 0.5 100 –
11 30 0.5 100 0.5 100 –
12 120 1.5 100 0.5 100 –
Table 1 Gradient used on the
loading pump and eluting pump
for the TFC-LC (ESI)-MS/MS
analysis of the milk samples
Loading pump—A: 0.1% formic
acid and 0.05% trifluoroacetic
acid in water; B: methanol; C:
isopropanol:acetone (1/1, v/v);
D: 2% acetonitrile and 0.1%
ammonium hydroxide in water
Eluting pump—A: 0.1% formic
acid and 0.01% trifluoroacetic
acid in water; B: methanol
Analyte Precursor ion (m/z) Product 1 CE (V) Product 2 CE (V)
Albendazole 266.1 234.0 15 191.0 31
Sulphamethazine 279.1 124.2 14 108.0 16
Phenylbutazone 309.2 211.3 16 188.3 15
Difloxacin 400.1 356.1 20 299.1 27
Spiramycin 422.0 174.0 35 350.5 12
Tetracycline 445.5 410.0 17 427.0 6
Oxytetracycline 461.1 426.0 19 201.0 36
Salinomycin-Na 773.4 265.4 50 432.0 44
Table 2 Selected ion transitions
for the monitoring of the
different analytes by TFC-LC-
(ESI)-MS/MS
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The matrix effect was studied by comparing the results
obtained for spiked milk samples and direct injection of the
standard solutions with the same concentrations of veteri-
nary drugs. A mixture of standards at 100 µg/L level was
prepared in methanol and analysed by TFC-LC-MS/MS.
The area counts for each analyte were then compared with
the one obtained on the analysis of the same mixture in
matrix (milk). Two different milk samples were studied and
referenced as A (low fat milk) and B (whole-fat milk).
The robustness of the developed method was tested by
comparing the results obtained for different milk samples
with low, medium and high fat content.
Application
The method was applied to the analysis of 12 raw milk
samples. For testing purposes, some of the milk samples were
fortified with a veterinary drug. This set of samples was
analysed using the developed TFC-LC-MS/MS method. All
samples were previously analysed by the authors using a
normal routine LC-MS/MS method with offline sample
preparation [3] and were found negative. Negative means
less than the EU MRL for the specific compounds in milk.
For albendazole, sulphamethazine, tetracycline and oxytetra-
cycline negative means <100 µg/L, for spiramycine
<200 µg/L and for the non-MRL substances phenylbutazone,
difloxacin, salinomycin-Na, negative means <10 µg/L.
The routine analysis of the raw milk samples by TFC-
LC-MS/MS was performed by a technician not aware of the
concentration of drugs residues present in the samples. In
this way, the method was tested for false positive and
negative results.
Results and discussion
Method development
Four steps were considered when developing the TFC-
method. The first consisted of a loading step and involved
the loading of the sample and sufficient washing of the TFC
column to remove the matrix. Water containing 2%
acetonitrile and 0.1% ammonium hydroxide proved to be
suitable for removing the matrix from the TFC column
while retaining the analytes of interest. The second step was
the transfer step in which the analytes of interest were
desorbed from the TFC column onto the analytical column.
At this stage, the TFC flow rate was decreased before its in-
line mixing with the low organic content delivered from
elution pump of the analytical column. Lowering the
organic content prevented the dispersion of the analytes in
the analytical column and consequent peak broadening.
Methanol proved to be the most suitable solvent for
complete recovery of the analytes from the TFC column.
The third step is the actual chromatographic separation on
the analytical LC column using an elution gradient. The
fourth and last step was the equilibration in which the initial
conditions were set for the next run. Note that equilibration
and loading of the TFC column for the next run can already
start before the end of the analytical separation. To avoid
carry-over, the composition of the conditioning solution for
the TFC column was also tested. A mixture of isopropanol
and acetone (1/1) was selected as most suitable.
Method validation
All spiked samples were found positive in the screening
analysis. That means that no false negative results were
obtained for the analysis of all the spiked samples. The
samples analysed without the addition of veterinary drugs
were all screened negative. Table 3 presents the results
obtained for the linearity and repeatability. The linearity
was found to be good with the exception of spiramycin low
fat, and oxytetracycline whole milk. On both cases, the
correlation coefficient was below 0.99. Calibration curves
constructed based on neat standard solutions appear to be
linear within the range of 5–500 µg/L. For repeatability,
RSD below 15% were obtained for the majority of the
analysis, with sulphamethazine and difloxacin for whole
milk and at the highest level (500 µg/L), as the exceptions.
This is an indication that the method developed is able to
successfully separate the matrix from the analytes of
interest. The same was confirmed by the analysis of a
blank milk sample. No major interferences were found at
the analytes' retention times.
A representative SRM chromatogram is shown in Fig. 2.
The concentration level selected was 100 µg/L. Unambig-
uous peaks were observed for each transition monitored
(only one SRM transition shown) demonstrating the good
performance of the extraction procedure. However, it
should be kept in mind that the development of multi-
residue methods using mass spectrometric detection often
leads to instrumental parameter settings that are adequate
for the determination of all analytes but are not necessarily
optimal for individual analytes. Furthermore, when dealing
with on-line sample preparation methodologies like turbu-
lent flow chromatography, factors such as the pH during
extraction may be crucial for an efficient extraction
procedure. Therefore, compromises need to be made, but
in such a way that the desired analytical requirements as
linearity, repeatability and limits of detection will be met
for all the compounds present in the method.
Since the peak intensity of an LC-MS/MS signal is
related to the ionisation efficiency of the individual analyte
while passing from the solution phase to the gas phase, the
ionisation efficiency of the targeted compounds plays an
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essential role in defining the accuracy of the measurements.
The ionisation efficiency can be either suppressed or
enhanced due to the presence of other materials, often
related to the matrix. The co-elution of other compounds,
either originating from the matrix or simply other analytes
present in the sample, can influence the response and
therefore interfere with the quantification. Electrospray
ionisation (ESI) is reported to be more likely impacted by
these factors than atmospheric pressure chemical ionisation
(APCI). The main cause for ion suppression is a change in
the spray droplet solution properties caused by the presence
of non-volatile or less volatile solutes. These compounds
can change the efficiency of droplet formation or droplet
evaporation, which in turn affects the amount of charged
ion in the gas phase that ultimately reaches the detector.
One objective of this study was to evaluate how co-eluting
matrix interferences would influence the relative response
for our selected analytes.
For this study, the standards and the samples are treated
exactly the same namely dilution, centrifugation, injection.
Therefore, the matrix effects are representative of recovery
for this method. Table 4 presents the results of matrix
effects (ion suppression or enhancement), LODs and carry-
over. It can be seen that ion suppression was dominant, but
also that signal enhancement was found for difloxacin and
tetracycline in milk samples A and B and for oxytetracy-
cline in milk sample A (low fat) only. If a comparison is
made between the two samples, it can be concluded that the
change in the response (either suppression or enhancement)
is similar in both samples of milk. This indicates that the
composition of the samples is probably similar and that the
different fat content does not introduce additional variabil-
ity into the analysis. Phenylbutazone and difloxacin are the
exception since the differences in signal suppression and
enhancement for the two samples of milk are relatively
large compared to the other compounds.
Albendazole is the analyte most affected by matrix
effects and also the one showing the highest carry-over
value. However, 1.2% is still below the lowest point of the
selected calibration range. Albendazole also presented the
Table 3 The variation in linearity (r2), slope, intercept and repeatability (RSD%) on the TFC-LC-(ESI)-MS/MS analysis of different fat content
milk samples (n=3)
Milk Sample Non-Fat Low Fat (2%) Whole Milk 
Fortification Level (µg/L) 50 100 250 500 50 100 250 500 50 100 250 500 
r2 
y = - 199899+32597 x 
0.9984 
y = -312516 + 36317 x 
0.9967 
y = -454265 + 36722 x  
0.9928 Albendazole RSD 
(%) 1.6 1.7 1.7 2.7 6.3 3.2 3.6 4.2 2.6 6.2 1.2 2.9 
r2 
y = 291 + 580 x 
0.9964 
y = 5511 + 529 x 
0.9908 
y = 2153 + 638 x 
0.9970 Sulphamethazine RSD 
(%) 2.4 7.2 4.9 2.4 6.6 14.5 5.2 5.6 8.9 1.2 5.1 18.4 
r2 
y = -211312 + 6023.8 x 
0.9947 
y = -305494 + 7911 x 
0.9922 
y = -420552 +7391 x 
0.9963 Phenylbutazone 
RSD 
(%) 2.9 3.3 0.8 2.6 8.1 4.1 4.9 3.1 0.6 0.9 0.7 0.3 
r2 
y = 444653 + 23806 x 
0.9958 
y = 309858 + 24725 x 
0.9907 
y = 173467 + 27985 x 
0.9968 Difloxacin RSD 
(%) 12.2 4.3 6.0 2.4 10.8 4.6 2.7 5.5 2.6 6.1 5.1 15.4 
r2 
y = 19898 + 333 x 
0.9920 
y = 6170 + 418 x 
0.9740 
y = 5433 + 476 x 
0.9951 Spiramycin RSD 
(%) 11.1 11.8 8.4 4.1 10.9 4.0 10.0 9.4 13.3 6.5 5.2 0.2 
r2 
y = -15636 + 3095 x 
0.9923 
y = -31979 + 3179 x 
0.9948 
y = -71774 + 3787 x 
0.9903 Tetracycline RSD 
(%) 6.2 6.4 5.4 3.7 7.3 4.8 5.9 4.5 4.1 9.5 6.5 5.5 
r2 
y = -4096 + 1135 x 
0.9947 
y = -2099 + 1192 x 
0.9922 
y = -23879 + 1439 x 
0.9663 Oxytetracycline RSD 
(%) 2.9 3.3 0.8 2.6 8.1 4.1 4.9 3.1 0.6 0.9 0.7 0.3 
r2 
y = 1655380 + 123984 x 
0.9993 
y = 1797080 + 125248 x 
0.9966 
y = 171219 + 141990 x 
0.9984 Salinomycin-Na RSD 
(%) 1.2 0.7 1.2 1.5 1.5 0.8 3.1 0.4 2.8 3.1 1.3 1.2 
RSD% of the repeatability for the specific sample type/concentration level (n=3)
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lowest limit of detection, 0.4 µg/L. On the contrary,
tetracycline was the least affected by the presence of the
matrix. It is expected that the conditions selected in this
method, e.g., pH used on the extraction procedure, favour
certain groups in relation to others, due to the different
chemical properties of each analyte. The method seems to
be closer to optimum to compounds belonging to the
tetracycline family, macrolides and even ionophores than to
the benzimidazoles.
Aguilera-Luiz et al. [6] also observed matrix effects by
the analysis of veterinary drug in milk. For some
benzimidazoles and quinolones, they observed enhance-
ment effects and for the levamisol and abamectin signifi-
cant ion suppression effects. However, they did not
quantify these effects. Furthermore, they concluded—like
in the present study—that there was no significant influence
of the sample composition. In other words, almost no
differences in matrix effects between non-fat, whole-fat and
medium-fat milk samples.
The LODs ranged from 0.4 to 5.2 µg/L (see Table 4) and
are far below the MRLs. According to new EU guidelines
for the validation of a screening method (CRL document of
20/1/2010 Guidelines for the validation of screening
methods for residues of veterinary medicines—initial
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Fig. 2 Representative SRM
chromatograms of a non-fat
milk sample spiked with the
mixture of antibiotics standards
at 100 µg/L level and analysed
by TFC-LC-(ESI)-MS/MS. See
Table 2 for details
Analyte Relative responsea (%) LODb (µg/L) Carry-overc (%)
A = Low fat milk B = Whole fat milk
Albendazole −82 −85 0.4 1.2
Sulphamethazine −57 −59 1.6 0
Phenylbutazone −69 −25 1.9 0
Difloxacin 70 40 1.7 0.6
Spiramycin −28 −37 5.2 0
Tetracycline 8 8 2.4 0
Oxytetracycline 31 −5 3.0 0
Salinomycin-Na −19 −31 0.7 0.2
Table 4 Relative responses
(%), LODs and carry-over at
100 µg/L level
a Relative response (%)=(Area
milk sample/Area neat
standard−1) × 100
b Limit of detection in matrix
c Carry-over (%)=(Area blank/
Area milk sample (level
500 µg/L))×100
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validation and transfer1), a cut-off level has to be
established for each analyte/matrix combination. A cut-off
level is defined as the level which indicates that a
confirmatory test has to be performed. For non-MRL
substances the cut-off have to be as low as possible
preferably around the LOD and for MRL substances the
cut-off has to be preferably around 1/2 MRL. With the very
low LODs obtained with the present method, these required
cut-off levels were obtained.
While some matrix effects remain for all the analytes the
developed method has proved to be linear, repeatable and low
limits of detection were obtained. Also, the results appear to
be consistent for the different samples studied indicating that
similar results can be obtained when samples originating from
different sources are analysed. Carry-over was minimal for
most of the analytes which indicates that the solutions
involved in the cleaning process are efficient on removing
any residues from the system between injections.
Application
The results of the analysis of the series of raw milk samples
are presented in Table 5.
From the results, it is concluded that no false negatives
or positives were found. However, lower amounts of
tetracyclines were found in samples 10 and 11. These
analytes were not added to the sample. The amount
detected is close to their limit of detection and one can
question if these analytes were already present in the blank
sample used. The concentrations detected are far below the
MRLs and so these concentrations will not be picked up in
regular LC-MS/MS method used for monitoring purposes.
While the concentration found for sulphamethazine in
sample 12 is correct, the oxytetracycline concentration
found in sample 11 is five times higher than expected.
Signal enhancement due to matrix components alone cannot
account for this overestimation and better quantification
results may have been obtained if an internal standard is
used. Nevertheless, the method was able to detect all the
compounds present in the blind samples, proving to be a fast
and efficient screening tool. In practical applications, the
three positive samples from this screening would have been
re-analysed for confirmation purposes, thus confirming true
findings and removing any false positives.
Conclusion
A new method for the automated multi-residue screening of
antibiotics in milk is proposed. It combines turbulent flow
chromatography for analyte extraction and purification with
LC-MS/MS for analytical separation and detection of the
analytes. The advantages of this method are the reduced
sample preparation time and higher sample throughput.
Albendazole, sulphamethazine, phenylbutazone, diflox-
acin, spiramycine, tetracycline, oxytetracycline, and
salinomycin-Na were isolated, detected and quantified in
milk by TFC-LC-ESI-MS/MS. Sample pre-treatment was
limited to diluting and centrifugation. Even without internal
standards, good linearity was obtained in the concentration
range of 50 to 500 µg/L (for neat standard in the range
5–500 µg/L) as well as repeatability (RSDs<15% excep-
tion: sulphamethazine and difloxacin at 500 µg/L <20%).
The limits of detection were between 0.1 and 5.2 µg/L. The
limits of detection found were far below the MRLs of the
tested analytes. While matrix effects (ion suppression or
enhancement) were obtained for all the analytes the method
has proved to be useful for screening purposes because of
its sensitivity. The results appear to be consistent for the
1 See http://ec.europa.eu/food/food/chemicalsafety/residues/Guideline_
Validation_Screening_en.pdf.
Sample Analytes added Analysis by TFC-LC-(ESI)-MS/MS
01 None Negative
02 None Negative
03 None Negative
04 None Negative
05 None Negative
06 None Negative
07 None Negative
08 None Negative
09 None Negative
10 None Oxytetracycline 5 µg/L
11 Oxytetracycline 200 µg/L Oxytetracycline 1 mg/L Tetracycline 5 µg/L
12 Sulphamethazine 200 µg/L Sulphamethazine 200 µg/L
Table 5 Testing the method as
a routine procedure
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different samples tested indicating that similar results can
be obtained when samples originating from different
sources are analysed. Carry-over was minimal for most of
the analytes which indicates that the solutions involved in
the cleaning process are efficient on removing any residues
from the system between injections.
The developed TFC-LC-MS/MS method is a quick and
sensitive screening method for automated multi-residue
screening of veterinary drugs in milk.
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